Serum MicroRNA-191-5p Levels in Vascular Complications of Type 1 Diabetes: The EURODIAB Prospective Complications

Stefania Bellini1, Simonetta Guarrera2,3, Giuseppe Matullo1,4

  • 1Department of Medical Sciences, University of Turin, 10126 Turin, Italy.

Abstract

Insights

Serum levels of microRNA-191-5p were significantly lower in type 1 diabetes patients with chronic vascular complications. Lower microRNA-191-5p levels are independently associated with an increased risk of diabetic complications, including cardiovascular disease and albuminuria.

Area of Science:

  • Biochemistry
  • Genetics
  • Endocrinology

Background:

  • MicroRNA-191-5p plays a role in cellular processes relevant to diabetic complications like angiogenesis and inflammation.
  • Circulating microRNA-191-5p levels in chronic diabetes complications have not been previously studied.

Purpose of the Study:

  • To investigate the association between serum microRNA-191-5p levels and micro- and macrovascular disease in type 1 diabetes mellitus (DM1).

Main Methods:

  • Quantitative PCR was used to measure microRNA-191-5p levels in 420 DM1 patients from the EURODIAB Prospective Complication Study.
  • Logistic regression analysis was employed to assess the independent association of microRNA-191-5p with diabetes complications, comparing cases (with complications) and controls (without complications).

Main Results:

  • MicroRNA-191-5p levels were significantly reduced in DM1 patients with chronic complications compared to controls.
  • Reduced microRNA-191-5p was independently associated with a lower odds of developing chronic diabetes complications, including cardiovascular disease, albuminuria, and retinopathy.

Conclusions:

  • Serum microRNA-191-5p is inversely associated with vascular chronic complications in type 1 diabetes mellitus.
  • Lower levels of microRNA-191-5p may serve as a potential biomarker for predicting the risk of vascular complications in DM1.

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
989
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
590